TENX insider buying

5 cluster buys

TENAX THERAPEUTICS, INC.

When two or more insiders at TENAX THERAPEUTICS, INC. buy TENX in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in TENX plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
5
Distinct insiders
8
Total bought
$6.6M
Market cap
Unknown

Detected clusters

  • Aug 20 – Oct 21, 2026
    Detected Oct 21, 2026
    Executive buyer4 insiders
    Total bought
    $6.4M
    Market cap
    Unknown
  • Aug 20 – Sep 16, 2026
    Detected Sep 18, 2026
    Executive buyer4 insiders
    Total bought
    $4.9M
    Market cap
    Unknown
  • Aug 20 – Sep 15, 2026
    Detected Sep 16, 2026
    Executive buyer3 insiders
    Total bought
    $4.8M
    Market cap
    Unknown

2 more clusters in TENX

Choose Basic for full history, or Pro for email and Telegram alerts after new insider clusters are detected. Both plans start with a 7-day trial.

All notable open-market buys in TENX

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Oct 21, 2026
10% Owner
331,979$1.66$550.7KSEC ↗
Oct 20, 2026
10% Owner
254,342$1.60$405.7KSEC ↗
Oct 19, 2026
10% Owner
336,528$1.51$507.0KSEC ↗
Sep 16, 2026
Director
53,000$1.92$101.8KSEC ↗
Sep 15, 2026
Director, CEO
4,850$1.82$8.8KSEC ↗
Sep 11, 2026
Director, CEO
6,000$1.88$11.3KSEC ↗
Sep 11, 2026
Chief Financial Officer
5,675$1.94$11.0KSEC ↗
Sep 3, 2026
10% Owner
900,000$1.78$1.6MSEC ↗
Sep 2, 2026
10% Owner
187,704$1.80$337.6KSEC ↗
Sep 1, 2026
10% Owner
179,058$1.80$321.6KSEC ↗
Aug 31, 2026
10% Owner
403,571$1.79$722.6KSEC ↗
Aug 24, 2026
10% Owner
107,374$1.75$188.4KSEC ↗
Aug 21, 2026
10% Owner
716,369$1.77$1.3MSEC ↗
Aug 20, 2026
10% Owner
202,124$1.78$359.5KSEC ↗
Dec 9, 2025
Director, Chief Medical Officer
2,500$10.22$25.6KSEC ↗
Dec 8, 2025
Director, Chief Medical Officer
2,500$10.10$25.3KSEC ↗
Dec 4, 2025
Director, Chief Medical Officer
2,500$9.20$23.0KSEC ↗
Dec 3, 2025
Director, Chief Medical Officer
1,500$9.08$13.6KSEC ↗
Dec 2, 2025
Director, Chief Medical Officer
1,000$9.01$9.0KSEC ↗
Nov 20, 2025
Director, CEO
538$7.59$4.1KSEC ↗
Nov 19, 2025
Director, CEO
455$7.51$3.4KSEC ↗
Nov 18, 2025
Director
1,900$7.52$14.3KSEC ↗
Nov 18, 2025
Director, CEO
1,612$7.75$12.5KSEC ↗
Nov 17, 2025
Interim CFO
5,000$7.23$36.2KSEC ↗
Nov 17, 2025
Interim CFO
2,000$7.34$14.7KSEC ↗
2 earlier buys hidden — sign in free to see the full history.

TENX insider buying — FAQ

Are insiders buying TENX stock?
Yes — 8 distinct insiders have bought TENX (TENAX THERAPEUTICS, INC.) on the open market, including 5 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Oct 21, 2026.
How much TENX stock have insiders bought?
Insiders have bought a combined $6.6M of TENX across 27 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in TENX?
A cluster buy is two or more distinct TENAX THERAPEUTICS, INC. insiders — officers, directors, or 10% owners — each buying TENX on the open market within a rolling window. TENX has 5 detected cluster buys to date.
Where does this TENX insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in TENX

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy TENX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding TENX.